首页 > 最新文献

Expert Review of Gastroenterology & Hepatology最新文献

英文 中文
Per-oral endoscopic myotomy (POEM) in achalasia: why length matters. 经口内窥镜下肌切开术治疗贲门失弛缓症:为什么长度很重要。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-05 DOI: 10.1080/17474124.2026.2620718
Anthony J Kang, John E Pandolfino, A Aziz Aadam

Introduction: Per-oral endoscopic myotomy (POEM) is a minimally-invasive, effective treatment option in patients with non-spastic and spastic achalasia, and is continuously evolving toward a personalized, tailored approach for patients.

Areas covered: This article reviews the procedural aspects of POEM, its efficacy in the treatment of non-spastic and spastic achalasia, adverse events, and how it compares to other first-line therapies including pneumatic dilation and laparoscopic Heller myotomy with partial fundoplication. It also describes the evolution of tailored therapy in patients, including short-tailored myotomy in non-spastic achalasia and manometry-directed myotomy in spastic achalasia. This review is based on data from randomized controlled trials, systematic reviews, meta-analyses, and comparative studies from PubMed over the past 20 years, and primarily over the past 5-10 years.

Expert opinion: POEM has continuously moved toward personalized medicine, offering tailored therapy to a patient's specific phenotype. Delivering effective therapy while minimizing the major disadvantages of POEM (e.g. gastroesophageal reflux, esophagitis, and blown-out myotomy) would be a milestone in achalasia therapy. A movement toward a short-tailored myotomy in non-spastic achalasia and manometry-directed therapy for spastic achalasia may provide these answers.

经口内窥镜下肌切开术(POEM)是治疗非痉挛性和痉挛性失弛缓症的一种微创、有效的治疗选择,并不断向个性化、量身定制的方法发展。涵盖的领域:本文回顾了POEM的程序方面,它在治疗非痉挛性和痉挛性失弛缓症中的疗效,不良事件,以及它与其他一线治疗方法的比较,包括气动扩张和腹腔镜Heller肌切开术。它还描述了患者量身定制治疗的发展,包括非痉挛性失弛缓症的短定制肌切开术和痉挛性失弛缓症的压力测量定向肌切开术。本综述基于PubMed过去20年,主要是过去5-10年的随机对照试验、系统综述、荟萃分析和比较研究的数据。专家意见:POEM不断向个性化医疗迈进,为患者的特定表型提供量身定制的治疗。提供有效的治疗,同时最大限度地减少POEM的主要缺点(如胃食管反流、食管炎和爆裂性肌切开术)将是贲门失弛缓症治疗的一个里程碑。在非痉挛性失弛缓症中采用短切口肌切开术和在痉挛性失弛缓症中采用压力测量定向治疗可能提供这些答案。
{"title":"Per-oral endoscopic myotomy (POEM) in achalasia: why length matters.","authors":"Anthony J Kang, John E Pandolfino, A Aziz Aadam","doi":"10.1080/17474124.2026.2620718","DOIUrl":"10.1080/17474124.2026.2620718","url":null,"abstract":"<p><strong>Introduction: </strong>Per-oral endoscopic myotomy (POEM) is a minimally-invasive, effective treatment option in patients with non-spastic and spastic achalasia, and is continuously evolving toward a personalized, tailored approach for patients.</p><p><strong>Areas covered: </strong>This article reviews the procedural aspects of POEM, its efficacy in the treatment of non-spastic and spastic achalasia, adverse events, and how it compares to other first-line therapies including pneumatic dilation and laparoscopic Heller myotomy with partial fundoplication. It also describes the evolution of tailored therapy in patients, including short-tailored myotomy in non-spastic achalasia and manometry-directed myotomy in spastic achalasia. This review is based on data from randomized controlled trials, systematic reviews, meta-analyses, and comparative studies from PubMed over the past 20 years, and primarily over the past 5-10 years.</p><p><strong>Expert opinion: </strong>POEM has continuously moved toward personalized medicine, offering tailored therapy to a patient's specific phenotype. Delivering effective therapy while minimizing the major disadvantages of POEM (e.g. gastroesophageal reflux, esophagitis, and blown-out myotomy) would be a milestone in achalasia therapy. A movement toward a short-tailored myotomy in non-spastic achalasia and manometry-directed therapy for spastic achalasia may provide these answers.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"93-105"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146040542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of yoga therapy in intestinal disorders. 瑜伽疗法对肠道疾病的影响。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-10 DOI: 10.1080/17474124.2026.2628016
Giovanni Santacroce, Alessandra Cocchi, Antonio Di Sabatino

Introduction: Intestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colorectal cancer (CRC) are rising in prevalence worldwide. Despite medical advances, many patients experience persistent symptoms and impaired quality of life (QoL), highlighting the need for integrative, non-pharmacological approaches.

Areas covered: This review explores the physiological and clinical impact of yoga therapy in intestinal disorders, examining its effects on neural, intestinal, and microbial pathways. A structured literature search was conducted in PubMed for studies published from database inception to August 2025, to identify relevant clinical trials and meta-analyses across IBS, IBD, and CRC. Evidence suggests yoga improves symptom control, stress resilience, QoL, and may exert anti-inflammatory and neuromodulatory effects.

Expert opinion: Yoga therapy presents a low-risk, potentially cost-effective adjunct to conventional care, with applicability across diverse gastrointestinal conditions. Future integration into clinical practice will depend on overcoming barriers such as protocol variability, lack of clinician awareness, and limited reimbursement. Advancements in biomarker research, digital therapeutics, and personalized treatment models will shape the field. In the next decades, yoga therapy may become a standard, personalized component of integrative care in gastroenterology.

肠易激综合征(IBS)、炎症性肠病(IBD)和结直肠癌(CRC)等肠道疾病在世界范围内的患病率正在上升。尽管医学取得了进步,但许多患者经历了持续的症状和生活质量(QoL)受损,这突出了综合非药物治疗方法的必要性。涵盖领域:本综述探讨了瑜伽疗法对肠道疾病的生理和临床影响,检查了它对神经、肠道和微生物途径的影响。在PubMed中对从数据库建立到2025年8月发表的研究进行了结构化文献检索,以确定IBS, IBD和CRC的相关临床试验和荟萃分析。有证据表明,瑜伽可以改善症状控制、压力恢复能力、生活质量,并可能发挥抗炎和神经调节作用。专家意见:瑜伽疗法是一种低风险、具有潜在成本效益的传统护理辅助疗法,适用于各种胃肠道疾病。未来整合到临床实践将取决于克服障碍,如方案的可变性,缺乏临床医生的认识,和有限的报销。生物标志物研究、数字治疗和个性化治疗模式的进步将塑造这一领域。在接下来的几十年里,瑜伽疗法可能会成为胃肠病学综合护理的一个标准、个性化的组成部分。
{"title":"Impact of yoga therapy in intestinal disorders.","authors":"Giovanni Santacroce, Alessandra Cocchi, Antonio Di Sabatino","doi":"10.1080/17474124.2026.2628016","DOIUrl":"10.1080/17474124.2026.2628016","url":null,"abstract":"<p><strong>Introduction: </strong>Intestinal disorders such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and colorectal cancer (CRC) are rising in prevalence worldwide. Despite medical advances, many patients experience persistent symptoms and impaired quality of life (QoL), highlighting the need for integrative, non-pharmacological approaches.</p><p><strong>Areas covered: </strong>This review explores the physiological and clinical impact of yoga therapy in intestinal disorders, examining its effects on neural, intestinal, and microbial pathways. A structured literature search was conducted in PubMed for studies published from database inception to August 2025, to identify relevant clinical trials and meta-analyses across IBS, IBD, and CRC. Evidence suggests yoga improves symptom control, stress resilience, QoL, and may exert anti-inflammatory and neuromodulatory effects.</p><p><strong>Expert opinion: </strong>Yoga therapy presents a low-risk, potentially cost-effective adjunct to conventional care, with applicability across diverse gastrointestinal conditions. Future integration into clinical practice will depend on overcoming barriers such as protocol variability, lack of clinician awareness, and limited reimbursement. Advancements in biomarker research, digital therapeutics, and personalized treatment models will shape the field. In the next decades, yoga therapy may become a standard, personalized component of integrative care in gastroenterology.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"119-134"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to predict abnormal acid reflux: recent developments. 如何预测异常胃酸反流:最新进展。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-09 DOI: 10.1080/17474124.2026.2628950
Yu Kyung Cho, Donghoon Kang, Jae Myung Park

Introduction: Recent advances in physiology and technology have led to the identification of additional parameters that have the potential to enhance diagnostic accuracy and inform the management of Gastroesophageal reflux disease (GERD). Whilst traditional pH monitoring and acid exposure time (AET) remain central to diagnosis, recent advances have introduced novel physiological markers that improve diagnostic accuracy, especially in cases where results are inconclusive.

Areas covered: This review summarizes recent advances in predicting abnormal acid reflux. Novel physiologic indices include baseline impedance as markers of mucosal integrity, and the post-reflux swallow-induced peristaltic wave (PSPW) as a measure of chemical clearance. High resolution esophageal manometry (HRM) provides indirect evidence through EGJ contractile integral (EGJ-CI), multiple rapid swallows, and straight leg raise testing. Finally, artificial intelligence (AI) offers powerful methods to automate reflux event detection, PSPW calculation, and endoscopic classification, reducing interobserver variability and supporting precision diagnosis.

Expert opinion: While AET remains central, novel physiologic metrics and AI integration substantially enhance prediction of abnormal acid reflux, particularly in patients with borderline findings. The standardization of thresholds and validation in large multicentre studies is required for the establishment of these tools in clinical practice.

导读:生理学和技术的最新进展导致了额外参数的识别,这些参数有可能提高诊断准确性,并为胃食管反流病(GERD)的管理提供信息。虽然传统的pH监测和酸暴露时间(AET)仍然是诊断的核心,但最近的进展引入了新的生理标志物,提高了诊断的准确性,特别是在结果不确定的情况下。涉及领域:本文综述了预测异常胃酸反流的最新进展。新的生理指标包括基线阻抗作为粘膜完整性的标志,以及反流后吞咽诱导的蠕动波(PSPW)作为化学清除的测量。高分辨率食管测压仪(HRM)通过EGJ收缩积分(EGJ- ci)、多次快速吞咽和直腿抬高测试提供间接证据。最后,人工智能(AI)提供了强大的方法来自动检测反流事件、计算PSPW和内镜分类,减少观察者之间的差异,支持精确诊断。专家意见:虽然AET仍然是核心,但新的生理指标和人工智能的结合大大增强了对异常酸反流的预测,特别是在有边缘性发现的患者中。为了在临床实践中建立这些工具,需要在大型多中心研究中标准化阈值和验证。
{"title":"How to predict abnormal acid reflux: recent developments.","authors":"Yu Kyung Cho, Donghoon Kang, Jae Myung Park","doi":"10.1080/17474124.2026.2628950","DOIUrl":"10.1080/17474124.2026.2628950","url":null,"abstract":"<p><strong>Introduction: </strong>Recent advances in physiology and technology have led to the identification of additional parameters that have the potential to enhance diagnostic accuracy and inform the management of Gastroesophageal reflux disease (GERD). Whilst traditional pH monitoring and acid exposure time (AET) remain central to diagnosis, recent advances have introduced novel physiological markers that improve diagnostic accuracy, especially in cases where results are inconclusive.</p><p><strong>Areas covered: </strong>This review summarizes recent advances in predicting abnormal acid reflux. Novel physiologic indices include baseline impedance as markers of mucosal integrity, and the post-reflux swallow-induced peristaltic wave (PSPW) as a measure of chemical clearance. High resolution esophageal manometry (HRM) provides indirect evidence through EGJ contractile integral (EGJ-CI), multiple rapid swallows, and straight leg raise testing. Finally, artificial intelligence (AI) offers powerful methods to automate reflux event detection, PSPW calculation, and endoscopic classification, reducing interobserver variability and supporting precision diagnosis.</p><p><strong>Expert opinion: </strong>While AET remains central, novel physiologic metrics and AI integration substantially enhance prediction of abnormal acid reflux, particularly in patients with borderline findings. The standardization of thresholds and validation in large multicentre studies is required for the establishment of these tools in clinical practice.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"171-189"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146124311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of reference values of cardiorespiratory fitness and impact of interventions in patients with cirrhosis. 肝硬化患者心肺健康参考值及干预措施影响的meta分析。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-02-01 Epub Date: 2026-02-03 DOI: 10.1080/17474124.2026.2623009
Alexis Couret, Fabrice Rannou, Bruno Pereira, Martine Duclos, James A King, Sebastien Dharancy, Remi Nevière, Delphine Weil-Verhoeven, Gaël Ennequin, Armand Abergel

Introduction: Cirrhosis is associated with significant risk of comorbidity and early mortality. Cardiopulmonary exercise testing has the advantage of allowing cardiac, pulmonary and muscle function assessment and could have a better prognosis value than the usual assessment of cardiorespiratory function often evaluated at rest in patients with cirrhosis.

Methods: We reviewed electronic databases (PubMed, Scopus, Embase, Google Scholar) for relevant literature running up to April 2024.

Results: This review gathers the data from 3029 patients with cirrhosis from 62 studies. Patients with cirrhosis had lower cardiorespiratory fitness (CRF) than age-matched healthy subjects and reference values were meta-analyzed. VO2Peak (mL.min-1.kg-1) and anaerobic threshold (mL.min-1.kg-1) were significantly lower in Child-Pugh C compared to A (p = 0.009) and B (p < 0.001). Supervised exercise proved effective for improving VO2Peak (p < 0.001) before and after transplantation (p < 0.001), but not when conducted in a home-based setting (p = 0.569). Liver transplantation initially (at three months) results in a minor decrease in CRF, but over time (at 12 months) leads to an improvement in CRF.

Conclusion: This meta-analysis provides reference values for CRF in patients with cirrhosis and shows the benefits of supervised physical exercise before and after liver transplantation. CRF could help clinicians to prioritize patients on the LT waiting list.

肝硬化与合并症和早期死亡的显著风险相关。心肺运动试验的优点是可以评估心脏、肺和肌肉功能,比通常在肝硬化患者静息时评估的心肺功能有更好的预后价值。方法:检索PubMed、Scopus、Embase、谷歌Scholar等电子数据库截止到2024年4月的相关文献。结果:本综述收集了来自62项研究的3029例肝硬化患者的数据。肝硬化患者的心肺适能(CRF)低于年龄匹配的健康受试者,并对参考值进行meta分析。Child-Pugh C组的VO2Peak (mL.min-1.kg-1)和厌氧阈(mL.min-1.kg-1)均显著低于A组(p = 0.009)和B组(p p p = 0.569)。肝移植最初(3个月)导致CRF轻微下降,但随着时间的推移(12个月)导致CRF改善。结论:本荟萃分析为肝硬化患者的CRF提供了参考价值,并显示了肝移植前后有监督的体育锻炼的益处。CRF可以帮助临床医生优先考虑肝移植等待名单上的患者。
{"title":"Meta-analysis of reference values of cardiorespiratory fitness and impact of interventions in patients with cirrhosis.","authors":"Alexis Couret, Fabrice Rannou, Bruno Pereira, Martine Duclos, James A King, Sebastien Dharancy, Remi Nevière, Delphine Weil-Verhoeven, Gaël Ennequin, Armand Abergel","doi":"10.1080/17474124.2026.2623009","DOIUrl":"10.1080/17474124.2026.2623009","url":null,"abstract":"<p><strong>Introduction: </strong>Cirrhosis is associated with significant risk of comorbidity and early mortality. Cardiopulmonary exercise testing has the advantage of allowing cardiac, pulmonary and muscle function assessment and could have a better prognosis value than the usual assessment of cardiorespiratory function often evaluated at rest in patients with cirrhosis.</p><p><strong>Methods: </strong>We reviewed electronic databases (PubMed, Scopus, Embase, Google Scholar) for relevant literature running up to April 2024.</p><p><strong>Results: </strong>This review gathers the data from 3029 patients with cirrhosis from 62 studies. Patients with cirrhosis had lower cardiorespiratory fitness (CRF) than age-matched healthy subjects and reference values were meta-analyzed. VO2Peak (mL.min-1.kg-1) and anaerobic threshold (mL.min-1.kg-1) were significantly lower in Child-Pugh C compared to A (<i>p</i> = 0.009) and B (<i>p</i> < 0.001). Supervised exercise proved effective for improving VO2Peak (<i>p</i> < 0.001) before and after transplantation (<i>p</i> < 0.001), but not when conducted in a home-based setting (<i>p</i> = 0.569). Liver transplantation initially (at three months) results in a minor decrease in CRF, but over time (at 12 months) leads to an improvement in CRF.</p><p><strong>Conclusion: </strong>This meta-analysis provides reference values for CRF in patients with cirrhosis and shows the benefits of supervised physical exercise before and after liver transplantation. CRF could help clinicians to prioritize patients on the LT waiting list.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"157-170"},"PeriodicalIF":2.5,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146061065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives. 脂肪肝的指南比较:欧洲(EASL-EASD-EASO)和亚洲(APASL)的观点。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-19 DOI: 10.1080/17474124.2025.2607008
Ludovico Abenavoli

Introduction: Metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) represent an increasing global health challenge for modern medicine. Europe and Asia have responded with region-specific guidelines -respectively, European Association for the Study of the Liver (EASL)-European Association for the Study of Diabetes (EASD)-European Association for the Study of Obesity (EASO) for MASLD and Asian Pacific Association for the Study of the Liver (APASL) for MAFLD- that reflect different epidemiology, clinical priorities and healthcare systems.

Areas covered: We compare the two guidelines on the basis of three main points: 1) definitions and diagnostic strategies, 2) treatment and in particular lifestyle and pharmacological options, and 3) surveillance approaches.

Expert opinion: Both guidelines agree on the central role of lifestyle management and early diagnosis. However, there are several differences in diagnosis, pharmacotherapy, and surveillance. The European approach supports targeted fibrosis assessment using fibrosis-4 and transient elastography. On the other hand, the Asian-Pacific framework provides broader coverage, including special populations. What our analysis suggests is a harmonization, to be reached via global consensus, that balances precision medicine with inclusivity and that supports collaborative, cross-regional research that focuses on closing the gaps of current knowledge.

代谢功能障碍相关的脂肪性肝病(MAFLD)和代谢功能障碍相关的脂肪性肝病(MASLD)代表了现代医学日益增长的全球健康挑战。欧洲和亚洲分别制定了区域性的指南——欧洲肝脏研究协会(EASL)、欧洲糖尿病研究协会(EASD)、欧洲肥胖研究协会(EASO)针对MASLD和亚太肝脏研究协会(APASL)针对MAFLD——这些指南反映了不同的流行病学、临床重点和医疗保健系统。涵盖领域:我们在三个主要方面比较两个指南:1)定义和诊断策略,2)治疗,特别是生活方式和药物选择,以及3)监测方法。来源包括2024年EASL-EASD-EASO联合指南和2025年APASL临床实践指南。专家意见:两份指南都认同生活方式管理和早期诊断的核心作用。然而,在诊断、药物治疗和监测方面存在一些差异。欧洲方法支持使用纤维化-4和瞬时弹性成像进行靶向纤维化评估。另一方面,亚太框架提供了更广泛的覆盖面,包括特殊人群。我们的分析表明,要通过全球共识达成协调,在精准医疗与包容性之间取得平衡,并支持以缩小当前知识差距为重点的协作性跨区域研究。
{"title":"Guideline comparison for fatty liver disease: European (EASL-EASD-EASO) and Asian (APASL) perspectives.","authors":"Ludovico Abenavoli","doi":"10.1080/17474124.2025.2607008","DOIUrl":"10.1080/17474124.2025.2607008","url":null,"abstract":"<p><strong>Introduction: </strong>Metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD) represent an increasing global health challenge for modern medicine. Europe and Asia have responded with region-specific guidelines -respectively, European Association for the Study of the Liver (EASL)-European Association for the Study of Diabetes (EASD)-European Association for the Study of Obesity (EASO) for MASLD and Asian Pacific Association for the Study of the Liver (APASL) for MAFLD- that reflect different epidemiology, clinical priorities and healthcare systems.</p><p><strong>Areas covered: </strong>We compare the two guidelines on the basis of three main points: 1) definitions and diagnostic strategies, 2) treatment and in particular lifestyle and pharmacological options, and 3) surveillance approaches.</p><p><strong>Expert opinion: </strong>Both guidelines agree on the central role of lifestyle management and early diagnosis. However, there are several differences in diagnosis, pharmacotherapy, and surveillance. The European approach supports targeted fibrosis assessment using fibrosis-4 and transient elastography. On the other hand, the Asian-Pacific framework provides broader coverage, including special populations. What our analysis suggests is a harmonization, to be reached via global consensus, that balances precision medicine with inclusivity and that supports collaborative, cross-regional research that focuses on closing the gaps of current knowledge.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"5-9"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional imaging: a game changer for biomarker discovery and treatment response among patients with hepatocellular carcinoma. 功能成像:肝细胞癌患者生物标志物发现和治疗反应的游戏规则改变者
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-25 DOI: 10.1080/17474124.2025.2607569
Shadi Afyouni, Ghazal Zandieh, Timothy M Pawlik, Ihab R Kamel

Introduction: Liver cancer, particularly hepatocellular carcinoma (HCC), is a leading cause of cancer-related mortality worldwide. Traditional imaging techniques including CT and MRI provide valuable anatomical data but often overlook the liver's functional heterogeneity, which is crucial for accurate diagnosis and personalized treatment.

Areas covered: This review explores advancements in functional imaging modalities, including contrast-enhanced ultrasound (CEUS), diffusion-weighted imaging (DWI), dynamic contrast-enhanced MRI (DCE-MRI), and PET/CT, which provide detailed insights into tumor biology and treatment response in HCC. CEUS enables real-time assessment of hepatic microvascular perfusion with excellent temporal resolution and without ionizing radiation. DCE-MRI and perfusion CT permit time-resolved quantification of perfusion kinetics and vascular permeability, offering surrogate biomarkers of tumor angiogenesis and treatment response. PET/CT, through tracers captures regional variations in metabolism, reflecting tumor viability and functional reserve.

Expert opinion: Collectively, these modalities advance precision imaging by linking physiological and metabolic information to morphologic findings, thereby improving diagnostic accuracy, risk stratification, and therapy monitoring in hepatocellular carcinoma.

肝癌,特别是肝细胞癌(HCC),是世界范围内癌症相关死亡的主要原因。包括CT和MRI在内的传统成像技术提供了宝贵的解剖学数据,但往往忽略了肝脏功能的异质性,这对于准确诊断和个性化治疗至关重要。涵盖领域:本综述探讨了功能成像方式的进展,包括对比增强超声(CEUS)、扩散加权成像(DWI)、动态对比增强MRI (DCE-MRI)和PET/CT,它们提供了对HCC肿瘤生物学和治疗反应的详细见解。超声造影能够实时评估肝脏微血管灌注,具有优异的时间分辨率和无电离辐射。DCE-MRI和灌注CT允许灌注动力学和血管通透性的时间分辨量化,提供肿瘤血管生成和治疗反应的替代生物标志物。PET/CT通过示踪剂捕获代谢的区域变化,反映肿瘤的生存能力和功能储备。专家意见:总的来说,这些模式通过将生理和代谢信息与形态学发现联系起来,提高了精确成像,从而提高了肝细胞癌的诊断准确性、风险分层和治疗监测。
{"title":"Functional imaging: a game changer for biomarker discovery and treatment response among patients with hepatocellular carcinoma.","authors":"Shadi Afyouni, Ghazal Zandieh, Timothy M Pawlik, Ihab R Kamel","doi":"10.1080/17474124.2025.2607569","DOIUrl":"10.1080/17474124.2025.2607569","url":null,"abstract":"<p><strong>Introduction: </strong>Liver cancer, particularly hepatocellular carcinoma (HCC), is a leading cause of cancer-related mortality worldwide. Traditional imaging techniques including CT and MRI provide valuable anatomical data but often overlook the liver's functional heterogeneity, which is crucial for accurate diagnosis and personalized treatment.</p><p><strong>Areas covered: </strong>This review explores advancements in functional imaging modalities, including contrast-enhanced ultrasound (CEUS), diffusion-weighted imaging (DWI), dynamic contrast-enhanced MRI (DCE-MRI), and PET/CT, which provide detailed insights into tumor biology and treatment response in HCC. CEUS enables real-time assessment of hepatic microvascular perfusion with excellent temporal resolution and without ionizing radiation. DCE-MRI and perfusion CT permit time-resolved quantification of perfusion kinetics and vascular permeability, offering surrogate biomarkers of tumor angiogenesis and treatment response. PET/CT, through tracers captures regional variations in metabolism, reflecting tumor viability and functional reserve.</p><p><strong>Expert opinion: </strong>Collectively, these modalities advance precision imaging by linking physiological and metabolic information to morphologic findings, thereby improving diagnostic accuracy, risk stratification, and therapy monitoring in hepatocellular carcinoma.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"29-38"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145780664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathology and characteristics of colorectal polyps in a Sub-Saharan setting-implications for local colon cancer screening. 撒哈拉以南地区结直肠息肉的组织病理学和特征——对当地结肠癌筛查的意义。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-09 DOI: 10.1080/17474124.2025.2600379
Amoako Duah, Dominic Amakye, Paddy Ssentongo, Kofi Clarke

Background: Colorectal cancer (CRC) is a leading cause of global cancer-related mortality and morbidity, with rising incidence in Sub-Saharan African countries over the past decade. This study aims to determine the prevalence, and describe location, as well as histopathology of polyps in patients undergoing colonoscopy in Ghana. The prevalence and polyp characteristics provide additional data and have implications for developing locally relevant screening guidelines.

Research design and methods: Retrospective chart review of patients ≥18 years who completed a colonoscopy at the anonymized from 1 January 2021 to 31 December 2023.

Results: 510 patients were included in the analysis. The mean age was 54.8 (±0.7 SD); 62% were males. Abnormal findings included hemorrhoids (47.1%), polyps (30.0%), diverticular disease (10.2%), and colonic mass (2.4%). Overall adenoma detection rate (ADR) was 26.1%. Histopathology showed 30.8% tubular adenoma, 30.1% hyperplastic polyps, and 16.0% tubulovillous adenoma. The highest burden of polyps was in the 60- to 80-year-old age group. The prevalence of CRC was 2.2% in our study.

Conclusions: CRC prevalence rates remain relatively low in Sub-Saharan Africa. Access to screening is limited, and the numbers may be underestimated. A cost-effective screening strategy to improve early detection and outcomes is needed.

背景:结直肠癌(CRC)是全球癌症相关死亡率和发病率的主要原因,在过去十年中,撒哈拉以南非洲国家的发病率不断上升。本研究的目的是确定患病率,并描述位置,以及在加纳接受结肠镜检查的患者息肉的组织病理学。息肉的患病率和特征提供了额外的数据,并对制定当地相关的筛查指南具有重要意义。研究设计和方法:回顾性分析2021年1月1日至2023年12月31日匿名完成结肠镜检查的≥18岁患者的图表。结果:510例患者纳入分析。平均年龄54.8岁(±0.7 SD);62%是男性。异常表现包括痔疮(47.1%)、息肉(30.0%)、憩室疾病(10.2%)和结肠肿块(2.4%)。总腺瘤检出率(ADR)为26.1%。病理表现为管状腺瘤30.8%,增生性息肉30.1%,管状绒毛腺瘤16.0%。60至80岁年龄组的息肉负担最高。在我们的研究中,CRC的患病率为2.2%。结论:撒哈拉以南非洲地区的CRC患病率仍然相对较低。接受筛查的机会有限,而且人数可能被低估。需要一种具有成本效益的筛查策略,以改善早期发现和结果。
{"title":"Histopathology and characteristics of colorectal polyps in a Sub-Saharan setting-implications for local colon cancer screening.","authors":"Amoako Duah, Dominic Amakye, Paddy Ssentongo, Kofi Clarke","doi":"10.1080/17474124.2025.2600379","DOIUrl":"10.1080/17474124.2025.2600379","url":null,"abstract":"<p><strong>Background: </strong>Colorectal cancer (CRC) is a leading cause of global cancer-related mortality and morbidity, with rising incidence in Sub-Saharan African countries over the past decade. This study aims to determine the prevalence, and describe location, as well as histopathology of polyps in patients undergoing colonoscopy in Ghana. The prevalence and polyp characteristics provide additional data and have implications for developing locally relevant screening guidelines.</p><p><strong>Research design and methods: </strong>Retrospective chart review of patients ≥18 years who completed a colonoscopy at the anonymized from 1 January 2021 to 31 December 2023.</p><p><strong>Results: </strong>510 patients were included in the analysis. The mean age was 54.8 (±0.7 SD); 62% were males. Abnormal findings included hemorrhoids (47.1%), polyps (30.0%), diverticular disease (10.2%), and colonic mass (2.4%). Overall adenoma detection rate (ADR) was 26.1%. Histopathology showed 30.8% tubular adenoma, 30.1% hyperplastic polyps, and 16.0% tubulovillous adenoma. The highest burden of polyps was in the 60- to 80-year-old age group. The prevalence of CRC was 2.2% in our study.</p><p><strong>Conclusions: </strong>CRC prevalence rates remain relatively low in Sub-Saharan Africa. Access to screening is limited, and the numbers may be underestimated. A cost-effective screening strategy to improve early detection and outcomes is needed.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"57-62"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145700117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Introducing the "Guideline Comparison" article type. 介绍“指南比较”文章类型。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 DOI: 10.1080/17474124.2025.2607006
James H Tabibian
{"title":"Introducing the \"Guideline Comparison\" article type.","authors":"James H Tabibian","doi":"10.1080/17474124.2025.2607006","DOIUrl":"10.1080/17474124.2025.2607006","url":null,"abstract":"","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"1-3"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145773989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic and therapeutic strategies for biliary strictures: a comparison of ACG, ESGE, and ASGE guidelines. 胆道狭窄的诊断和治疗策略:ACG、ESGE和ASGE指南的比较
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2025-11-24 DOI: 10.1080/17474124.2025.2592076
Eyad Gadour, Stefano Francesco Crinò, Marco Spadaccini, Antonio Facciorusso

Introduction: The diagnostic management of biliary strictures remains a complex clinical challenge requiring evidence-based guidance. Multiple societies, including the European Society of Gastrointestinal Endoscopy (ESGE), American College of Gastroenterology (ACG), and American Society for Gastrointestinal Endoscopy (ASGE), have recently published guidelines with both consensus and divergence.

Areas covered: A comparative analysis of the ESGE, ACG, and ASGE guidelines reveals shared principles, such as the role of MRI/MRCP in initial evaluation (moderate quality evidence), limited utility of tumor markers alone (low to very low quality evidence), and preference for metal stents in palliation (moderate quality evidence). Key differences arise in tissue acquisition for perihilar strictures, with ACG/ASGE discouraging EUS-guided sampling in surgical candidates (low-quality evidence), while ESGE conditionally supports its use in non-resectable cases candidates (low-quality evidence). The ASGE provides conditional recommendations on bilateral stenting for malignant hilar obstruction, not emphasized in other guidelines.

Expert opinion: Although founded on similar evidence, guideline variations reflect differing risk tolerance and resource considerations. Clinicians must recognize these nuances to tailor management. Future research should clarify EUS seeding risk, evaluate cost-effectiveness, and inform harmonized guideline updates.

导言:胆道狭窄的诊断管理仍然是一个复杂的临床挑战,需要循证指导。包括欧洲胃肠内窥镜学会(ESGE)、美国胃肠病学学会(ACG)和美国胃肠内窥镜学会(ASGE)在内的多个学会最近发表了既有共识又有分歧的指南(表1)。涵盖领域:对ESGE、ACG和ASGE指南的比较分析揭示了共同的原则,例如MRI/MRCP在初始评估中的作用(中等质量证据),单独使用肿瘤标志物的有限效用(低到极低质量证据),以及在缓解中首选金属支架(中等质量证据)。关键的差异在于门静脉周围狭窄的组织采集,ACG/ASGE不鼓励在手术候选人中进行eus引导采样(低质量证据),而ESGE有条件地支持在不可切除的候选人中使用(低质量证据)。ASGE提供了有条件的双侧支架治疗恶性肺门梗阻的建议,在其他指南中没有强调。专家意见:尽管基于相似的证据,指南的变化反映了不同的风险承受能力和资源考虑。临床医生必须认识到这些细微差别,以定制管理。未来的研究应明确EUS播种的风险,评估成本效益,并为统一的指南更新提供信息。
{"title":"Diagnostic and therapeutic strategies for biliary strictures: a comparison of ACG, ESGE, and ASGE guidelines.","authors":"Eyad Gadour, Stefano Francesco Crinò, Marco Spadaccini, Antonio Facciorusso","doi":"10.1080/17474124.2025.2592076","DOIUrl":"10.1080/17474124.2025.2592076","url":null,"abstract":"<p><strong>Introduction: </strong>The diagnostic management of biliary strictures remains a complex clinical challenge requiring evidence-based guidance. Multiple societies, including the European Society of Gastrointestinal Endoscopy (ESGE), American College of Gastroenterology (ACG), and American Society for Gastrointestinal Endoscopy (ASGE), have recently published guidelines with both consensus and divergence.</p><p><strong>Areas covered: </strong>A comparative analysis of the ESGE, ACG, and ASGE guidelines reveals shared principles, such as the role of MRI/MRCP in initial evaluation (moderate quality evidence), limited utility of tumor markers alone (low to very low quality evidence), and preference for metal stents in palliation (moderate quality evidence). Key differences arise in tissue acquisition for perihilar strictures, with ACG/ASGE discouraging EUS-guided sampling in surgical candidates (low-quality evidence), while ESGE conditionally supports its use in non-resectable cases candidates (low-quality evidence). The ASGE provides conditional recommendations on bilateral stenting for malignant hilar obstruction, not emphasized in other guidelines.</p><p><strong>Expert opinion: </strong>Although founded on similar evidence, guideline variations reflect differing risk tolerance and resource considerations. Clinicians must recognize these nuances to tailor management. Future research should clarify EUS seeding risk, evaluate cost-effectiveness, and inform harmonized guideline updates.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"11-16"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145539794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The pediatric medical liver biopsy: indications, procedures, and histopathology. 儿科医学肝活检:指征、程序和组织病理学。
IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-18 DOI: 10.1080/17474124.2025.2607575
Consolato M Sergi

Introduction: Investigative work in pediatric liver disease is rapidly growing. Despite noninvasive methods in place for several years, the medical liver biopsy is still a critical step for diagnosing and treating pediatric patients. We provide a narrative review focusing on indications, procedures, and histopathology of pediatric liver biopsy.

Areas covered: We searched the PubMed, Scopus, and Cochrane databases for articles on pediatric liver biopsy, discussing the clinical implications of several procedures and their associated costs. We also complemented our search by digging into the gray literature (e.g., reports, abstracts, textbooks, and Google Scholar) for similar items. The search for articles was conducted between 1 January 2022, and 31 July 2025.

Expert opinion: Pediatric liver biopsy is not limited to data gathered following formalin-fixation and paraffin-embedded liver tissue. It includes frozen tissue-based special stains, such as the oil red-O stain for lipids; a specimen devoted to ultrastructural analysis using a transmission electron microscope; and a flash-frozen tissue specimen used for future transcriptomics and genomic studies (e.g., single-nucleotide polymorphisms).

儿童肝病的调查工作正在迅速增长。尽管非侵入性方法已存在多年,但医学肝活检仍然是诊断和治疗儿科患者的关键步骤。我们提供了一个叙述性的回顾,重点是指征,程序和组织病理学的儿童肝活检。涉及领域:我们检索了PubMed, Scopus和Cochrane数据库中关于儿童肝脏活检的文章,讨论了几种手术的临床意义及其相关费用。我们还通过挖掘灰色文献(例如报告、摘要、教科书和谷歌Scholar)来补充我们的搜索。对文章的搜索在2022年1月1日至2025年7月31日之间进行。专家意见:儿童肝活检不限于福尔马林固定和石蜡包埋肝组织后收集的数据。它包括基于冷冻组织的特殊染色,例如用于脂质的油红- o染色,用于透射电子显微镜的超微结构分析的标本,以及用于未来转录组学和基因组研究(例如单核苷酸多态性)的快速冷冻组织标本。
{"title":"The pediatric medical liver biopsy: indications, procedures, and histopathology.","authors":"Consolato M Sergi","doi":"10.1080/17474124.2025.2607575","DOIUrl":"10.1080/17474124.2025.2607575","url":null,"abstract":"<p><strong>Introduction: </strong>Investigative work in pediatric liver disease is rapidly growing. Despite noninvasive methods in place for several years, the medical liver biopsy is still a critical step for diagnosing and treating pediatric patients. We provide a narrative review focusing on indications, procedures, and histopathology of pediatric liver biopsy.</p><p><strong>Areas covered: </strong>We searched the PubMed, Scopus, and Cochrane databases for articles on pediatric liver biopsy, discussing the clinical implications of several procedures and their associated costs. We also complemented our search by digging into the gray literature (e.g., reports, abstracts, textbooks, and Google Scholar) for similar items. The search for articles was conducted between 1 January 2022, and 31 July 2025.</p><p><strong>Expert opinion: </strong>Pediatric liver biopsy is not limited to data gathered following formalin-fixation and paraffin-embedded liver tissue. It includes frozen tissue-based special stains, such as the oil red-O stain for lipids; a specimen devoted to ultrastructural analysis using a transmission electron microscope; and a flash-frozen tissue specimen used for future transcriptomics and genomic studies (e.g., single-nucleotide polymorphisms).</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"39-56"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145803520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert Review of Gastroenterology & Hepatology
全部 Geobiology Appl. Clay Sci. Geochim. Cosmochim. Acta J. Hydrol. Org. Geochem. Carbon Balance Manage. Contrib. Mineral. Petrol. Int. J. Biometeorol. IZV-PHYS SOLID EART+ J. Atmos. Chem. Acta Oceanolog. Sin. Acta Geophys. ACTA GEOL POL ACTA PETROL SIN ACTA GEOL SIN-ENGL AAPG Bull. Acta Geochimica Adv. Atmos. Sci. Adv. Meteorol. Am. J. Phys. Anthropol. Am. J. Sci. Am. Mineral. Annu. Rev. Earth Planet. Sci. Appl. Geochem. Aquat. Geochem. Ann. Glaciol. Archaeol. Anthropol. Sci. ARCHAEOMETRY ARCT ANTARCT ALP RES Asia-Pac. J. Atmos. Sci. ATMOSPHERE-BASEL Atmos. Res. Aust. J. Earth Sci. Atmos. Chem. Phys. Atmos. Meas. Tech. Basin Res. Big Earth Data BIOGEOSCIENCES Geostand. Geoanal. Res. GEOLOGY Geosci. J. Geochem. J. Geochem. Trans. Geosci. Front. Geol. Ore Deposits Global Biogeochem. Cycles Gondwana Res. Geochem. Int. Geol. J. Geophys. Prospect. Geosci. Model Dev. GEOL BELG GROUNDWATER Hydrogeol. J. Hydrol. Earth Syst. Sci. Hydrol. Processes Int. J. Climatol. Int. J. Earth Sci. Int. Geol. Rev. Int. J. Disaster Risk Reduct. Int. J. Geomech. Int. J. Geog. Inf. Sci. Isl. Arc J. Afr. Earth. Sci. J. Adv. Model. Earth Syst. J APPL METEOROL CLIM J. Atmos. Oceanic Technol. J. Atmos. Sol. Terr. Phys. J. Clim. J. Earth Sci. J. Earth Syst. Sci. J. Environ. Eng. Geophys. J. Geog. Sci. Mineral. Mag. Miner. Deposita Mon. Weather Rev. Nat. Hazards Earth Syst. Sci. Nat. Clim. Change Nat. Geosci. Ocean Dyn. Ocean and Coastal Research npj Clim. Atmos. Sci. Ocean Modell. Ocean Sci. Ore Geol. Rev. OCEAN SCI J Paleontol. J. PALAEOGEOGR PALAEOCL PERIOD MINERAL PETROLOGY+ Phys. Chem. Miner. Polar Sci. Prog. Oceanogr. Quat. Sci. Rev. Q. J. Eng. Geol. Hydrogeol. RADIOCARBON Pure Appl. Geophys. Resour. Geol. Rev. Geophys. Sediment. Geol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1